Lidocaine Hydrochloride Solution
NDC Package 71872-7357-1
Package Information
Lidocaine Hydrochloride solution is lidocaine Hydrochloride Injection, USP is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. This formulation utilizes a solution delivery system. Marketed by Medical Purchasing Solutions, Llc., this product is identified by NDC 71872-7357 and is authorized under FDA application ANDA212821.
Identification & Billing
- RxCUI: 1737761 - lidocaine HCl 2 % in 5 ML Injection
- RxCUI: 1737761 - 5 ML lidocaine hydrochloride 20 MG/ML Injection
- RxCUI: 1737761 - lidocaine HCl 100 MG per 5 ML Injection
- RxCUI: 1737761 - lidocaine HCl 2 % per 5 ML Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 71872 - Medical Purchasing Solutions, Llc.
- 71872-7357 - Lidocaine Hydrochloride
- 71872-7357-1 - 1 VIAL in 1 BAG / 5 mL in 1 VIAL
- 71872-7357 - Lidocaine Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71872-7357-1 identifies a specific commercial package of 1 vial in 1 bag / 5 ml in 1 vial of Lidocaine Hydrochloride, a human prescription drug labeled by Medical Purchasing Solutions, Llc.. This solution is formulated for intravenous use and contains lidocaine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Medical Purchasing Solutions, Llc. on June 15, 2023. The current certification is valid through December 31, 2026.
How is this Medical Purchasing Solutions, Llc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71872735701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.